<--- Back to Details
First PageDocument Content
Asthma / Phenethylamines / Chronic lower respiratory diseases / Combination drugs / Peak expiratory flow / Omalizumab / Salmeterol / Spirometry / Montelukast / Pulmonology / Medicine / Respiratory therapy
Date: 2013-06-26 08:34:09
Asthma
Phenethylamines
Chronic lower respiratory diseases
Combination drugs
Peak expiratory flow
Omalizumab
Salmeterol
Spirometry
Montelukast
Pulmonology
Medicine
Respiratory therapy

2012 National Ambulatory Medical Care Survey Asthma Supplement

Add to Reading List

Source URL: www.cdc.gov

Download Document from Source Website

File Size: 136,96 KB

Share Document on Facebook

Similar Documents

Medicine / Immunology / Immune system / Clinical medicine / Omalizumab / Immunoglobulin E / Allergen / Plasmacytoid dendritic cell / Allergy / Immunogen / TLR9 / Dendritic cell

Curing Allergic Diseases S-TARget therapeutics GmbH Mooslackengasse 17, 1190 Vienna, Austria. Phone:+, +, +Confidential

DocID: 1rgTJ - View Document

Medicine / Immunology / Clinical medicine / Immune system / Allergology / Glycoproteins / Monoclonal antibodies / Omalizumab / Immunoglobulin E / Asthma / Allergic conjunctivitis / Allergen

Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes

DocID: 1qs00 - View Document

Health / Health economics / Healthcare quality / Personal life / Quality-adjusted life year / Omalizumab / Quality of life / National Institute for Health and Care Excellence / ICD-10 / Life expectancy

Microsoft Word - VBP WSB implementation part 2 (December 12)

DocID: 1qi5u - View Document

Immune system / Blood tests / Monoclonal antibodies / Phadia / Glycoproteins / RTT / Omalizumab / Immunoglobulin E / Allergy

Milenia QuickLine Total IgE Beta side-Evaluation Milenia QuickLine Total IgE (MQTE) and Milenia POCScan (MSCAN) reader:

DocID: 1plJT - View Document

Medicine / Clinical medicine / Health care / Asthma / Immune system / Immunology / Allergology / Respiratory therapy / Allergy / Allergen / Epidemiology of asthma / Omalizumab

NATIONAL ACADEMY ON AN AGING SOCIETY The number of children with asthma has risen about 75 percent sinceIn 1996,

DocID: 1ljn3 - View Document